Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELEASE: Linagliptin for Arterial Stiffness in Early Diabetes
NCT02015299Phase 3Completed
- Start
- Mar 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM). Started Mar 2014; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02015299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015299.